Yunkang’s revenue grew only 8.8% YoY in 2021 excl. Cov-19 related tests (vs 80.2% growth from Cov tests) and we are yet to see major improvements excluding the positive impact on margins from COVID.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.